Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: A population-based cohort study

2021 ◽  
Vol 171 ◽  
pp. 108546
Author(s):  
Chen-Yi Wu ◽  
Chun-Ying Wu ◽  
Chung-Pin Li ◽  
Yiing-Jenq Chou ◽  
Yi-Hsian Lin ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Bullous Pemphigoid ◽  
Dipeptidyl Peptidase ◽  
Population Based ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitors

scholarly journals Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort study

2014 ◽  
Vol 74 (11) ◽  
pp. 1968-1975 ◽  
Author(s):  
Seoyoung C Kim ◽  
Sebastian Schneeweiss ◽  
Robert J Glynn ◽  
Michael Doherty ◽  
Allison B Goldfine ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Autoimmune Diseases ◽  
Dipeptidyl Peptidase ◽  
Population Based ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitors

scholarly journals Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

2014 ◽  
Vol 51 (6) ◽  
pp. 1015-1023 ◽  
Author(s):  
Seoyoung C. Kim ◽  
Robert J. Glynn ◽  
Jun Liu ◽  
Brendan M. Everett ◽  
Allison B. Goldfine
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Cardiovascular Events ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitors
Sign in / Sign up

Export Citation Format

Share Document